Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| plasma cell | 19 studies | 45% ± 17% | |
| type I pneumocyte | 11 studies | 30% ± 11% | |
| plasmablast | 9 studies | 50% ± 24% | |
| endothelial cell | 7 studies | 24% ± 8% | |
| epithelial cell | 7 studies | 27% ± 11% | |
| IgA plasma cell | 6 studies | 39% ± 14% | |
| IgG plasma cell | 6 studies | 36% ± 11% | |
| type II pneumocyte | 6 studies | 24% ± 6% | |
| macrophage | 5 studies | 24% ± 6% | |
| goblet cell | 5 studies | 30% ± 23% | |
| astrocyte | 4 studies | 27% ± 6% | |
| glutamatergic neuron | 4 studies | 38% ± 13% | |
| monocyte | 4 studies | 21% ± 5% | |
| club cell | 4 studies | 23% ± 6% | |
| alveolar macrophage | 4 studies | 28% ± 11% | |
| non-classical monocyte | 3 studies | 24% ± 8% | |
| GABAergic neuron | 3 studies | 38% ± 7% | |
| regulatory T cell | 3 studies | 17% ± 2% | |
| interneuron | 3 studies | 33% ± 17% | |
| oligodendrocyte | 3 studies | 19% ± 2% | |
| microglial cell | 3 studies | 21% ± 5% | |
| oligodendrocyte precursor cell | 3 studies | 23% ± 4% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
|---|---|---|---|---|---|---|
| esophagus | 100% | 2354.38 | 1445 / 1445 | 100% | 37.35 | 183 / 183 |
| kidney | 100% | 3168.11 | 89 / 89 | 100% | 53.73 | 901 / 901 |
| liver | 100% | 4501.28 | 226 / 226 | 100% | 50.28 | 406 / 406 |
| pancreas | 100% | 3350.27 | 328 / 328 | 100% | 48.82 | 178 / 178 |
| prostate | 100% | 3897.07 | 245 / 245 | 100% | 95.46 | 502 / 502 |
| stomach | 100% | 3359.91 | 359 / 359 | 100% | 42.21 | 286 / 286 |
| thymus | 100% | 5471.96 | 653 / 653 | 100% | 74.65 | 604 / 605 |
| lung | 100% | 5022.42 | 578 / 578 | 100% | 64.40 | 1153 / 1155 |
| breast | 100% | 3063.59 | 459 / 459 | 100% | 58.57 | 1116 / 1118 |
| ovary | 100% | 3019.23 | 180 / 180 | 100% | 36.62 | 429 / 430 |
| intestine | 100% | 3179.05 | 966 / 966 | 100% | 42.06 | 525 / 527 |
| uterus | 100% | 3037.22 | 170 / 170 | 100% | 45.26 | 457 / 459 |
| skin | 100% | 2539.60 | 1808 / 1809 | 99% | 47.50 | 469 / 472 |
| bladder | 100% | 2646.52 | 21 / 21 | 99% | 42.04 | 500 / 504 |
| adrenal gland | 100% | 2861.33 | 258 / 258 | 97% | 27.53 | 224 / 230 |
| brain | 95% | 1361.12 | 2504 / 2642 | 100% | 26.31 | 705 / 705 |
| adipose | 100% | 3002.66 | 1204 / 1204 | 0% | 0 | 0 / 0 |
| lymph node | 0% | 0 | 0 / 0 | 100% | 75.40 | 29 / 29 |
| muscle | 100% | 3268.14 | 803 / 803 | 0% | 0 | 0 / 0 |
| spleen | 100% | 5070.60 | 241 / 241 | 0% | 0 | 0 / 0 |
| tonsil | 0% | 0 | 0 / 0 | 100% | 44.65 | 45 / 45 |
| ureter | 0% | 0 | 0 / 0 | 100% | 27.49 | 1 / 1 |
| blood vessel | 100% | 3090.59 | 1334 / 1335 | 0% | 0 | 0 / 0 |
| peripheral blood | 98% | 3239.39 | 915 / 929 | 0% | 0 | 0 / 0 |
| heart | 98% | 1729.19 | 848 / 861 | 0% | 0 | 0 / 0 |
| eye | 0% | 0 | 0 / 0 | 98% | 37.68 | 78 / 80 |
| abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| GO_0005789 | Cellular component | endoplasmic reticulum membrane |
| GO_0005515 | Molecular function | protein binding |
| Gene name | TXNDC11 |
| Protein name | Thioredoxin domain-containing protein 11 (EF-hand-binding protein 1) Thioredoxin domain containing 11 |
| Synonyms | EFP1 |
| Description | FUNCTION: May act as a redox regulator involved in DUOX proteins folding. The interaction with DUOX1 and DUOX2 suggest that it belongs to a multiprotein complex constituting the thyroid H(2)O(2) generating system. It is however not sufficient to assist DUOX1 and DUOX2 in H(2)O(2) generation. |
| Accessions | I3L2Z6 Q6PKC3 ENST00000283033.10 [Q6PKC3-2] ENST00000356957.7 [Q6PKC3-1] ENST00000575591.1 I3L1A5 ENST00000571882.1 I3L0Q4 ENST00000576969.5 |